SEC Comment Letter for 89bio, Inc. (ETNB) (CIK 0001785173) — Apr 1, 2021
89bio, Inc. (ETNB) (CIK 0001785173)
Date: April 1, 2021 · CIK: 0001785173 · Accession: 0000000000-21-003922
AI Filing Summary & Sentiment
File numbers found in text: 333-254684
Letter
United States securities and exchange commission logo April 1, 2021 Rohan Palekar Chief Executive Officer 89bio, Inc. 142 Sansome Street, 2nd Floor San Francisco, CA 94104 Re:89bio, Inc. Registration Statement on Form S-3 Filed March 25, 2021 File No. 333-254684 Dear Mr. Palekar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Deanna Virginio at 202-551-4530 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan A. Murr, Esq.
Show Raw Text
United States securities and exchange commission logo
April 1, 2021
Rohan Palekar
Chief Executive Officer
89bio, Inc.
142 Sansome Street, 2nd Floor
San Francisco, CA 94104
Re:89bio, Inc.
Registration Statement on Form S-3
Filed March 25, 2021
File No. 333-254684
Dear Mr. Palekar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Deanna Virginio at 202-551-4530 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan A. Murr, Esq.